- Home
- CXAI vs TPST Comparison
CXAI vs TPST Comparison
Compare CXAI & TPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CXAI
- TPST
- Stock Information
- Founded
- CXAI N/A
- TPST 2011
- Country
- CXAI United States
- TPST United States
- Employees
- CXAI N/A
- TPST N/A
- Industry
- CXAI EDP Services
- TPST Biotechnology: Pharmaceutical Preparations
- Sector
- CXAI Technology
- TPST Health Care
- Exchange
- CXAI Nasdaq
- TPST Nasdaq
- Market Cap
- CXAI 26.7M
- TPST 27.2M
- IPO Year
- CXAI N/A
- TPST N/A
- Fundamental
- Price
- CXAI $1.82
- TPST $0.70
- Analyst Decision
- CXAI
- TPST Strong Buy
- Analyst Count
- CXAI 0
- TPST 4
- Target Price
- CXAI N/A
- TPST $20.00
- AVG Volume (30 Days)
- CXAI 1.9M
- TPST 1.4M
- Earning Date
- CXAI 11-12-2024
- TPST 11-12-2024
- Dividend Yield
- CXAI N/A
- TPST N/A
- EPS Growth
- CXAI N/A
- TPST N/A
- EPS
- CXAI N/A
- TPST N/A
- Revenue
- CXAI $7,200,000.00
- TPST N/A
- Revenue This Year
- CXAI $3.86
- TPST N/A
- Revenue Next Year
- CXAI $100.00
- TPST N/A
- P/E Ratio
- CXAI N/A
- TPST N/A
- Revenue Growth
- CXAI N/A
- TPST N/A
- 52 Week Low
- CXAI $1.03
- TPST $0.70
- 52 Week High
- CXAI $7.07
- TPST $6.00
- Technical
- Relative Strength Index (RSI)
- CXAI 54.43
- TPST 24.08
- Support Level
- CXAI $1.66
- TPST $0.86
- Resistance Level
- CXAI $1.96
- TPST $0.86
- Average True Range (ATR)
- CXAI 0.25
- TPST 0.07
- MACD
- CXAI 0.00
- TPST -0.01
- Stochastic Oscillator
- CXAI 33.89
- TPST 0.00
About CXAI CXApp Inc.
CXApp Inc is a workplace experience platform for enterprise customers. It is a SaaS product for enterprise organizations, distributing a mobile app to all employees within the organization. It includes a content management system (or CMS) so customers can adjust configurations for their workplace settings autonomously and spontaneously. Its technologies and solutions help enterprise customers deliver a comprehensive business journey in a work 'from anywhere' world for employees, partners, customers, and visitors. CXApp offers native mapping, analytics, on-device positioning (or ODP), and application technologies that bring people together.
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.